2024-09-10 - Analysis Report
## TMO Stock Analysis Report

**Company Overview:** TMO, Thermo Fisher Scientific Inc., is a leading provider of scientific instruments, reagents, consumables, and software for the life sciences, pharmaceutical, and industrial markets.

**1. Performance Comparison:**

* **Cumulative Return:** TMO has returned **112.77%**, outperforming the S&P 500 (VOO) by **31.43%**. This is **36.66%** of the maximum historical outperformance. 

**2. Recent Price Movement:**

* **Closing Price:** $611.33
* **5-day Moving Average:** $610.32
* **20-day Moving Average:** $607.20
* **60-day Moving Average:** $580.29

TMO's price is currently trading slightly above its 5-day moving average, suggesting recent upward momentum. However, it's below the 20-day and 60-day moving averages, indicating potential for further growth or a correction in the short term.

**3. Technical Indicators:**

* **RSI:** 56.12 (Neutral)
* **PPO:** -0.23 (Slight bearish signal)
* **Delta_Previous_Relative_Divergence:** 0.56 (Short-term downtrend)
* **Expected Return:** 55.68% (5-year projected return based on current investment)

TMO is currently experiencing a minor bearish signal as indicated by the PPO and the short-term downtrend. However, the RSI suggests neutral sentiment, and the expected return remains positive.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-02 | 4.05 | $10.54 B |
| 2024-05-03 | 3.47 | $10.35 B |
| 2023-11-03 | 4.44 | $10.57 B |
| 2023-08-04 | 3.53 | $10.69 B |
| 2024-08-02 | 3.53 | $10.69 B |

TMO's most recent earnings (2024-08-02) came in at $4.05 per share, beating analysts' estimates by $0.11. Revenue was $10.54 billion, exceeding estimates by $0.2 billion. The company continues to show consistent revenue growth, suggesting a healthy business environment.

**5. Overall Analysis:**

TMO has historically outperformed the S&P 500, demonstrating strong potential for future growth. While recent technical indicators suggest a slight bearish signal, the positive earnings results and overall healthy business environment suggest a strong outlook. The company's expected return of 55.68% further strengthens the case for investment in TMO.

**6. Conclusion:**

Despite the minor bearish signal, TMO remains a strong investment candidate. Its consistent earnings growth, robust business environment, and impressive long-term performance demonstrate its potential for continued success. Investors should continue to monitor technical indicators and consider the overall market environment before making any investment decisions.
